VH 032 Linker 2

Background Introduction

VH 032 Linker 2 is a specialized E3 ligase ligand-linker conjugate designed for the development of PROTACs (Proteolysis Targeting Chimeras). PROTAC technology utilizes bifunctional molecules to harness the ubiquitin-proteasome system for targeted protein degradation, offering a novel therapeutic approach to address previously 'undruggable' proteins. VH 032 is a well-established ligand for the E3 ligase VHL (von Hippel-Lindau), making this product highly valuable for researchers in drug discovery.

Mechanism

VH 032 Linker 2 functions as a modular component for PROTAC synthesis. It features a VH 032 moiety, which binds specifically to the VHL E3 ubiquitin ligase. The attached linker segment provides chemical handle(s) for conjugation to a ligand targeting the protein of interest. When integrated into a PROTAC molecule, VH 032 Linker 2 facilitates the recruitment of both the E3 ligase and the target protein, leading to ubiquitination and subsequent proteasomal degradation of the target protein.

Applications

VH 032 Linker 2 is ideal for researchers developing new PROTAC molecules aimed at selective protein degradation. Applications include creating targeted small molecule degraders for cancer, neurodegenerative diseases, and other therapeutic areas. Its proven efficacy as a VHL E3 ligand makes it invaluable for medicinal chemistry workflows, preclinical studies, and translational research focused on harnessing the power of targeted protein degradation technology.

• Optimized VH032-based linker ensures high binding affinity to VHL E3 ligase, improving PROTAC potency and selectivity.
• Versatile linker design enables efficient conjugation to diverse warheads, supporting flexible PROTAC development for targeted protein degradation.

The VH 032 Linker 2 serves as a crucial component in PROTACs, facilitating targeted protein degradation by connecting an E3 ligase ligand with a target protein ligand. This molecule offers enhanced specificity and efficiency in protein degradation applications, making it an invaluable tool for researchers exploring novel therapeutic strategies. The following provides a detailed description of this molecule.

Linker: The linker in VH 032 Linker 2 is a medium-length, flexible structure designed to provide optimal spatial orientation between the ligase and target protein ligands. It is non-cleavable, ensuring stability and sustained activity throughout the degradation process.

Ligand: The ligand is a high-affinity E3 ligase binder, specifically designed to interact with the von Hippel-Lindau (VHL) E3 ligase. Its structural characteristics include a robust binding motif that ensures efficient recruitment of the E3 ligase to the target protein complex.

Reactive Site: The reactive site in VH 032 Linker 2 is tailored for coupling with target protein ligands via amide bond formation. Recommended reaction types include amide coupling reactions using carbodiimide or HATU-mediated chemistry, offering reliable and efficient conjugation.

Recommended Target Protein Ligand: The compatible warhead for this molecule is typically an electrophilic moiety such as a chloroacetamide or acrylamide group. These warheads are advantageous for their ability to form covalent bonds with nucleophilic residues on target proteins, facilitating irreversible binding and degradation. This approach is ideal for applications requiring permanent inhibition of target proteins, such as in cancer research.